Digi Bio

Programmable bio-chips to automate experiments

Based based in Netherlands, Digi Bio works in ai machine learning, founded in 2017.

Profile

Digi.Bio is accelerating the development of life saving cell therapies with a lab-on-a-chip and computational platform that analyzes how cell therapies perform and evaluate their outcome down to the single cell level, delivering high content results in 24 hours and with minimal material waste.

The company sits in the ai machine learning segment, where it competes on its core product or service.

Its base of operations is Netherlands.

Directory data places it at the SOSV portfolio company stage.

Website: digi.bio